Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2013 Dec 31;8(12):e85166. doi: 10.1371/journal.pone.0085166. eCollection 2013.

MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.

Author information

1
Department of Urology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
2
Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
3
The First Clinical Medical College, Nanjing Medical University, Nanjing, China.
4
Department of Orthopedics, The Affiliated Hospital of Medical College, Qingdao University, Qingdao, China.

Abstract

BACKGROUND:

Cytochrome P450 1A1 (CYP1A1) is a member of the CYP1 family, which is a key enzyme in the metabolism of many endogenous substrates and exogenous carcinogens. To date, many studies have examined the association between CYP1A1 MspI and Ile462Val polymorphisms and cancer risk in various populations, but their results have been conflicting rather than consistent.

METHODS:

To assess this relationship more precisely, a meta-analysis based on 198 publications was performed. Odds ratios (OR) and corresponding 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with a chi-square-based Q-test.

RESULTS:

Overall, a significant elevated risk of cancer was associated with CYP1A1 MspI and Ile462Val polymorphisms for all genetic models studied. Further stratified analysis by cancer types revealed that the MspI polymorphism may increase the risk of lung cancer and cervical cancer whereas the Ile462Val polymorphism may contribute to a higher risk of lung cancer, leukemia, esophageal carcinoma, and prostate cancer. In the subgroup analysis by ethnicity, obvious associations were found in the Asian population for the MspI polymorphism while an increased risk of cancer was observed in Asians and Caucasians for the Ile462Val polymorphism.

CONCLUSIONS:

The results of this meta-analysis suggest that CYP1A1 MspI and Ile462Val polymorphisms contribute to increased cancer susceptibility among Asians. Additional comprehensive system analyses are required to validate this association and other related polymorphisms.

PMID:
24391993
PMCID:
PMC3877352
DOI:
10.1371/journal.pone.0085166
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center